Skip to main
ZYBT
ZYBT logo

ZYBT Market Capitalization Overview

Market Cap: $300.47M as of Jun 13, 2025

$300.47M
Past Month-$99.53M (24.88%)
As of Jun 13, 2025, ZYBT has a market capitalization of $300.47M. Over the past 30 days, its market cap has decreased by -12.18%, while in the last 12 months, it has increased by .

Market capitalization represents the total value of Zhengye Biotechnology Holding Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

ZYBT Market Cap Formula = Stock Price * Shares Outstanding

The market cap of ZYBT helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ZYBT Market Cap History

DateMarket CapChange
Jun 2, 2025$434.11M-12.18%
May 1, 2025$494.30M+96.05%
Apr 1, 2025$252.13M+20.09%
Mar 3, 2025$209.95M+3.04%
Feb 3, 2025$203.76M+267.23%
Jan 7, 2025$55.49M

ZYBT End of Year Market Cap History

DateMarket CapChange
2025$300.47M

FAQs About Zhengye Biotechnology Holding Ltd (ZYBT) Market Cap

As of Jun 13, 2025, the market capitalization of ZYBT is $300.47M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Zhengye Biotechnology Holding Ltd’s market capitalization has decreased by -24.88%, changing from $399.99M to $300.47M as of Jun 13, 2025.

In the last 3 months, Zhengye Biotechnology Holding Ltd’s market capitalization has increased by —, changing from – to – as of –.

In the year –, Zhengye Biotechnology Holding Ltd’s market capitalization increased from – in January to – in December, reflecting a — change.

Zhengye Biotechnology Holding Ltd (ZYBT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.